» Articles » PMID: 18313021

Early Infection with Leishmania Major Restrains Pathogenic Response to Leishmania Amazonensis and Parasite Growth

Overview
Journal Acta Trop
Publisher Elsevier
Specialty Tropical Medicine
Date 2008 Mar 4
PMID 18313021
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Experimental models of infection with Leishmania spp. have provided knowledge of several immunological events involved in the resistance mechanism used by the host to restrain parasite growth. It is well accepted that concomitant immunity exists, and there is some evidence that it would play a major role in long-lasting acquired resistance to infection. In this paper, the resistance to Leishmania amazonensis infection in C57BL/6 mice infected with Leishmania major was investigated. C57BL/6 mice, which spontaneously heal lesions caused by infection with L. major, were infected with L. amazonensis at different times before and after L. major. We demonstrated that C57BL/6 mice previously infected with L. major restrain pathogenic responses induced by L. amazonensis infection and decrease parasite burdens by one order of magnitude. Co-infected mice showed production of IFN-gamma in lesions similar to mice infected solely with L. major, but higher TNF-alpha and nitric oxide synthase (iNOS) mRNA expression was observed. Surprisingly, the restrained pathogenic response was not related to IL-10 production, as evidenced by lower levels of both mRNA, protein expression in lesions from co-infected mice and in co-infections in IL-10(-/-) mice. Examination of the inflammatory infiltrate at the site of infection showed a reduced number of monocytes and lymphocytes in L. amazonensis lesions. Additionally, differential production of the CCL3/MIP-1 alpha and CCL5/RANTES was observed. We suggest that the control of lesion progression caused by L. amazonensis in C57BL/6 mice pre-infected with L. major is related to the induction of a down-regulatory environment at the site of infection with L. amazonensis.

Citing Articles

An in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensis.

Gibson-Corley K, Bockenstedt M, Li H, Boggiatto P, Phanse Y, Petersen C PLoS One. 2014; 9(9):e106426.

PMID: 25191842 PMC: 4156363. DOI: 10.1371/journal.pone.0106426.


Interferon gamma in leishmaniasis.

Kima P, Soong L Front Immunol. 2013; 4:156.

PMID: 23801993 PMC: 3685816. DOI: 10.3389/fimmu.2013.00156.


Reactive oxygen species and nitric oxide in cutaneous leishmaniasis.

Horta M, Mendes B, Roma E, Noronha F, Macedo J, Oliveira L J Parasitol Res. 2012; 2012:203818.

PMID: 22570765 PMC: 3337613. DOI: 10.1155/2012/203818.


A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis.

Gibson-Corley K, Boggiatto P, Mukbel R, Petersen C, Jones D Int J Parasitol. 2009; 40(2):157-61.

PMID: 20004204 PMC: 2814795. DOI: 10.1016/j.ijpara.2009.11.010.